Why Is AlloVir (ALVR) Stock Up 30%?
AlloVir (NASDAQ:ALVR) stock is taking off on Wednesday following an update from the U.S. Food and Drug Administration (FDA) on posoleucel. Posoleucel is AlloVir’s lead investigational… Read More »Why Is AlloVir (ALVR) Stock Up 30%?